Literature DB >> 9731506

Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis.

C J Hsieh1, B Klump, K Holzmann, F Borchard, M Gregor, R Porschen.   

Abstract

Functional inactivation of the p16INK4a gene has been reported to be involved in the development of a variety of human malignancies. Recent evidence shows that transcriptional silencing as a consequence of hypermethylation of CpG islands is the predominant mechanism of p16INK4a gene inactivation in sporadic colon cancer. This study sought to identify the significance of p16INK4a methylation in the colonic epithelium of patients with long-standing ulcerative colitis. A total of 89 tissue samples was retrieved from three colectomy specimens. A methylation-specific PCR assay was applied. The methylation status was compared with histological findings and the flow cytometrically determined DNA index. Hypermethylation of the p16INK4a promoter region was detected in 12.7% of samples that were negative for dysplasia. However, 70.0% of samples with dysplasia and all of the samples with carcinomatous lesions revealed hypermethylation. Hypermethylation of the p16INK4a gene promoter was detected already in 40% of specimens with lesions indefinite for dysplasia and in 13.7% of samples with exclusively diploid cell populations. These results suggest that hypermethylation of the p16INK4a promoter region is a frequent and early occurring event during the process of neoplastic progression in ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731506

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  Epigenetic silencing of Kruppel like factor-3 increases expression of pro-metastatic miR-182.

Authors:  Mohit Sachdeva; Rebecca D Dodd; Zhiqing Huang; Carole Grenier; Yan Ma; Dina C Lev; Diana M Cardona; Susan K Murphy; David G Kirsch
Journal:  Cancer Lett       Date:  2015-08-24       Impact factor: 8.679

2.  Hypermethylation of TGF-β1 gene promoter in gastric cancer.

Authors:  Yong-Qi Wang; Yu-Min Li; Xun Li; Tao Liu; Xiao-Kang Liu; Jun-Qiang Zhang; Ju-Wu Guo; Ling-Yun Guo; Liang Qiao
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

3.  Methylation of multiple genes in gastric glands with intestinal metaplasia: A disorder with polyclonal origins.

Authors:  Mami Mihara; Yukinari Yoshida; Tetsuya Tsukamoto; Ken-ichi Inada; Yukihiro Nakanishi; Yukiko Yagi; Kohzoh Imai; Takashi Sugimura; Masae Tatematsu; Toshikazu Ushijima
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

4.  Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma.

Authors:  Francesca Cerimele; Traci Battle; Rebecca Lynch; David A Frank; Emma Murad; Cynthia Cohen; Nada Macaron; John Sixbey; Kenneth Smith; Randolph S Watnick; Aristidis Eliopoulos; Bahig Shehata; Jack L Arbiser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

Review 5.  DNA methylation as a marker for the past and future.

Authors:  Toshikazu Ushijima; Takeshi Nakajima; Takao Maekita
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

Review 6.  Epigenetic alterations in inflammatory bowel disease and cancer.

Authors:  Joo Mi Yi; Tae Oh Kim
Journal:  Intest Res       Date:  2015-04-27

7.  DNA methylation: a marker for carcinogen exposure and cancer risk.

Authors:  Takeshi Nakajima; Shotaro Enomoto; Toshikazu Ushijima
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

Review 8.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

Review 9.  Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.

Authors:  Masakazu Yashiro
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

10.  Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours.

Authors:  T Yoshida; N Matsumoto; T Mikami; I Okayasu
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.